Skip to main content

Advertisement

Log in

Damage did not independently influence mortality in childhood systemic lupus erythematosus

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Objective: To analyze clinical, laboratory and treatment features associated with death in a childhood-onset SLE population. Patients and methods: Patients with childhood-onset SLE followed at the State University of Campinas, Brazil, between 1980 and 2002 were included. Data on clinical and laboratory features of the disease were collected regularly. Logistic regression was used for analyzing association between clinical and laboratory features and death. Kaplan–Meyer tests were used to estimate the survival curves. Results: Of 61 patients identified, six were lost to follow-up during the first year of disease. The mean follow-up period of the remaining 55 patients was 3.25 years (SD=1.2). Mean SLICC/ACR-DI score was 4.9 (SD=3.4). Death occurred in 12 (21.8%) of 55 patients. Direct causes of death were: infection in six (50%), stroke in four (33.3%), and renal insufficiency in two (16.7%). Five patients (41.7%) died during the first 5 years of disease due to infection. Male gender (p=0.004; OR=9.1; 95% CI=7.6–21.0), infection (p=0.001; OR=4.2; 95% CI=1.6–15.2) and nephritis (p=0.02; OR=2.3; 95% CI=1.3–5.2) were independent factors associated with death in the multivariate analysis. The global survival rate adjusted for duration of disease was 93.9% in the first year of disease, 88.9% in the second year, 80.8% in the fifth year and 48.1% in 20 years of follow-up. When comparing survival curves, male gender, the presence of infection during the course of the disease and the presence of nephritis during follow-up had a worse survival. Conclusion: Male gender, the presence of infection and nephritis were independent risk factors for death in our Brazilian cohort. Damage did not independently influence survival in this study.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Domenech I et al (1993) Systemic lupus erythematosus: clinical and immunological patterns of disease expression in a cohort of 1000 patients. Medicine 72:113–124

    CAS  PubMed  Google Scholar 

  2. Nepom BS, Schaller JG (1984) Childhood systemic lupus erythematosus. Prog Clin Rheumatol 1:33–69

    Google Scholar 

  3. Schaller J (1982) Lupus in childhood. Clin Rheum Dis 8:219–228

    Google Scholar 

  4. Rosenberg AM (1994) Systemic lupus erythematosus in children. Springer Semin Immunopathol 16:216–279

    Article  Google Scholar 

  5. Costallat LTL, Coimbra AMV (1994) Systemic lupus erythematosus: clinical and laboratory aspects to age at disease onset. Clin Experim Rheumatol 12:603–607

    Google Scholar 

  6. Font J, Cervera R, Espinosa G, Pallares L, Ramos-Casals M, Jimenez S et al (1998) Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults. Ann Rheum Dis 57:456–459

    Google Scholar 

  7. Hashimoto H, Hiroshi T, Hirano T (1987) Differences in clinical and immunological findings of systemic lupus erythematosus related to age. J Rheumatol 14:497–501

    Google Scholar 

  8. Tan EM, Cohen AS, Fries JF et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277

    CAS  PubMed  Google Scholar 

  9. Liang MH, Corzillius M, Bae SC et al (1999) The American college nomenclature and case definitions for neuropsychiatric lupus syndrome. Arthritis Rheum 42:599–608

    Article  PubMed  Google Scholar 

  10. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630–640

    CAS  PubMed  Google Scholar 

  11. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, Hanly JG et al (1997) The reliability of the systemic lupus international collaborating clinics/American college of rheumatology damage index in patients with systemic lupus erythematosus. Arthritis Rheum 40:809–813

    Google Scholar 

  12. Brunner HI, Silverman ED, To T, Bombardier C, Feldman BM (2002) Factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 46:436–444

    Article  Google Scholar 

  13. Brandt JT, Triplett DA, Scharer I (1995) Criteria for the diagnosis of lupus anticoagulant: an update. Thromb Haemost 74:1185–1190

    CAS  PubMed  Google Scholar 

  14. Singsen BH (1990) Epidemiology of rheumatic diseases: rheumatic diseases in childhood. Rheum Dis Clin North Am 16:581–599

    Google Scholar 

  15. Dubois EL, Tuffanelli DL (1964) Clinical manifestations of systemic lupus erythematosus. JAMA 190:104–113

    CAS  PubMed  Google Scholar 

  16. Pande I, Sekharan NG, Kailash S, Uppal SS, Singh RR, Kumar A, Malaviya AN (1993) Analysis of clinical and laboratory profile in Indian childhood systemic lupus erythematosus and its comparison with SLE in adults. Lupus 2:83–87

    Google Scholar 

  17. Glidden RS, Mantzouranis EC, Borel Y (1983) Systemic lupus erythematosus in childhood: clinical manifestations and improved survival in 55 patients. Clin Immunol Immunopathol 29:196–210

    Article  Google Scholar 

  18. Lehman TJ, McCurdy DK, Bernstein BH, King KK, Hanson V (1989) Systemic lupus erythematosus in the first decade of life. Pediatrics 83:235–239

    Google Scholar 

  19. Marini R, Costallat LT (1999) Young age at onset, renal involvement, and arterial hypertension are of adverse prognostic significance in juvenile systemic lupus erythematosus. Rev Rhum Engl Ed 66:303–309

    Google Scholar 

  20. Gloor JM (1998) Lupus nephritis in children. Lupus 7:639–643

    Article  Google Scholar 

  21. Rood MJ, Ten Cate R, van Suijlekom-Smit LW, den Ouden EJ, Ouwerkerk FE, Breedveld FC, Huizinga TW (1999) Childhood-onset systemic lupus erythematosus: clinical presentation and prognosis in 31 patients. Scand J Rheumatol 28:222–226

    Article  Google Scholar 

  22. Emre S, Bilge I, Sirin A, Kilicaslan I, Nayir A, Oktem F, Uysal V (2001) Lupus nephritis in children: prognostic significance of clinicopathological findings. Nephron 87:118–126

    Article  Google Scholar 

  23. Lehman TJ (2001) Modern treatment of childhood SLE. Clin Exp Rheumatol 19:487–489

    Google Scholar 

  24. Gedalia A, Molina JF, Molina J, Uribe O, Malagon C, Espinoza LR (1999) Childhood-onset systemic lupus erythematosus: a comparative study of African Americans and Latin Americans. J Natl Med Assoc 91:497–501

    Google Scholar 

  25. Hagelberg S, Lee Y, Bargman J, Mah G, Schneider R, Laskin C, Eddy A et al (2002) Longterm followup of childhood lupus nephritis. J Rheumatol 29:2635–2642

    PubMed  Google Scholar 

  26. McCurdy DK, Lehman TJ, Bernstein B, Hanson V, King KK, Nadorra R, Landing BH (1992) Lupus nephritis: prognostic factors in children. Pediatrics 89:240–246

    Google Scholar 

  27. Haji Muhammad Ismail Hussain I, Loh WF, Sofiah A (1999) Childhood cerebral lupus in an Oriental population. Brain Dev 21:229–235

    Article  Google Scholar 

  28. Brunner HI, Feldman BM, Bombardier C, Silverman ED (1999) Sensitivity of the systemic lupus erythematosus disease activity index, British isles lupus assessment group index, and systemic lupus activity measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum 4:1354–1360

    Article  Google Scholar 

  29. Schor NF (2000) Neurology of systemic autoimmune disorders: a pediatric perspective. Semin Pediatr Neurol 7:108–117

    Google Scholar 

  30. Chan DQ (2000) Neurologic, ophthalmic, and neuropsychiatric manifestations of pediatric systemic lupus erythematosus. Optom Vis Sci 77:388–394

    Article  Google Scholar 

  31. Lee T, von Scheven E, Sandborg C (2001) Systemic lupus erythematosus and antiphospholipid syndrome in children and adolescents. Curr Opin Rheumatol 13:415–421

    Article  Google Scholar 

  32. Ward MM, Studenski S (1990) Systemic lupus erythematosus in men: a multivariate analysis of gender differences in clinical manifestations. J Rheumatol 17:220–224

    Google Scholar 

  33. Mok CC, Lau CS, Chan TM, Wong RW (1999) Clinical characteristics and outcome of southern Chinese males with systemic lupus erythematosus. Lupus 8:188–196

    Article  Google Scholar 

  34. Costallat LTL, Coimbra AM (1993) Systemic lupus erythematosus in 18 Brazilian males: clinical and laboratory analysis. Clin Rheumatol 12:522–525

    Google Scholar 

  35. Voulgari PV, Katsimbri P, Alamanos Y, Drosos AA (2002) Gender and age differences in systemic lupus erythematosus. A study of 489 Greek patients with a review of the literature. Lupus 11:722–729

    Article  Google Scholar 

  36. Mok CC, Lau CS, Chan TM, Wong RW (1999) Clinical characteristics and outcome of southern Chinese males with systemic lupus erythematosus. Lupus 8:188–196

    Article  Google Scholar 

Download references

Acknowledgement

The work was supported by Fundos Remanescentes da Sociedade Brasileira de Reumatologia

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Simone Appenzeller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Appenzeller, S., Marini, R. & Costallat, L.T. Damage did not independently influence mortality in childhood systemic lupus erythematosus. Rheumatol Int 25, 619–624 (2005). https://doi.org/10.1007/s00296-004-0552-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-004-0552-z

Keywords

Navigation